Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2022-08-03

Clinical Trial Update: Brain Irradiation and Tremelimumab in Metastatic Breast Cancer [NA]

View source ↗

Summary

Clinical trial update for brain irradiation and tremelimumab in metastatic breast cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tremelimumab (tremelimumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer | NA | Status: COMPLETED | Results posted: 2022-08-03